Huaxi Bio: The controlling shareholder intends to fulfill the donation agreement soon, donating 1% of the company's shares free of charge.

On May 11th, Huaxi Biotech announced that the company's controlling shareholder, Huaxi Xinyu Investment Co., Ltd., signed a "Donation Agreement" with Shandong University Education Foundation in 2023, agreeing to donate 4.8168 million shares of the company held by the donor to the recipient to support the development of medical education and technology at Shandong University. At the time of signing the "Donation Agreement", the subject shares were still in a lock-up period, and the donor and recipient agreed to deliver all subject shares as soon as possible in a lump sum after the lock-up period expires. On May 11, 2026, the company received a notification letter from the controlling shareholder, informing that they have reached an agreement with the recipient and intend to deliver the subject shares in the near future through non-trading transfer. The delivery of the subject shares this time is a public welfare donation by the controlling shareholder to fulfill the "Donation Agreement" to support the development of medical education and technology at Shandong University, and is not a reduction in shareholding by the controlling shareholder to obtain financial returns, which will not result in a change in the company's controlling shareholder and actual controller, and will not have a significant impact on the company's governance structure and continued operation.